Name: UMIN ID:
Unique ID issued by UMIN | UMIN000011680 |
---|---|
Receipt number | R000013519 |
Scientific Title | Multicenter Phese II Study of SOX plus Bevacizumab Therapy with Oxaliplatin Stop-and-Go Strategy and Oral S-1 plus Bevacizumab Maintenance Therapy in Advanced Colorectal CancerC |
Date of disclosure of the study information | 2013/09/08 |
Last modified on | 2016/11/16 09:07:21 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/09/08 11:23:50 | ||
2 | Update | 2016/03/08 13:57:40 | Control Interventions/Control_1 Interventions/Control_1 |
|
3 | Update | 2016/03/08 14:00:50 | Public title |
|
4 | Update | 2016/06/28 12:35:59 | UMIN ID1 |
|
5 | Update | 2016/11/16 09:07:01 | Name of person sending information Name of person sending information Name of primary person or sponsor Organization |
|
6 | Update | 2016/11/16 09:07:21 | Key inclusion criteria |